CEORater has published a number of CEO compensation studies over the years. The truth is we probably do not allocate sufficient weighting to compensation in our CEOs of The Year awards. The Wall Street Journal published an insightful piece on Technology Founder/CEO compensation, which we have previously written about. Our view is that public company … Continue reading CEO Compensation: What Happened To “Pay For Performance”?
Tag: CEO Compensation
Capital Markets professionals ingest every tidbit of industry and company-specific data under the sun in an effort to gain an edge toward Alpha generation. Yet, one large data set remains virtually untapped. That dataset is corporate Management Teams. It encompasses variations of traditional performance metrics such as equity ownership, Return on Invested Capital (ROIC), cash … Continue reading Management Team Analytics – The Last Frontier
We compared CEO compensation for the PLM Software sector. PTC (ticker: PTC) CEO Jim Heppelmann is the group outlier as his compensation is 3x the group average and 4x that of the CEO of the largest company in the group (by market value), Autodesk (ticker: ADSK) CEO Andrew Anagnost. See below for additional detail. https://soundcloud.com/ceorater
When a company Founder & CEO whom owns 14% of the company's equity pays himself $211 million (the approximate equivalent of one quarter's revenue), it sends the wrong message to the management team and employees (not to mention shareholders). Perhaps if Paycom Software (ticker: PAYC) were doubling Revenues and EBITDA each year for five or … Continue reading CEO Compensation Ought To Tightly Align With Company Performance
Over the past year Moderna (ticker: MRNA) insiders have sold equity worth approximately $292 million as of July 27th 2020. This includes CEO Stéphane Bancel whom has sold equity worth approximately $33 million and Chief Medical Officer Tal Zaks whom has sold equity worth approximately $55 million over the same period. MRNA insider sales. Click … Continue reading Moderna Insider Sales Raise Corporate Governance Flags
CVS Health (ticker: CVS) provides an example of ineffective executive compensation management. Compensation should reward past performance and encourage behavior that drives desired future results. CEO total compensation growth should not outpace revenue growth nor operating cash flow growth over time. We prefer operating cash flow as a performance metric over Adjusted EBITDA as some … Continue reading CVS Health: An Example of Ineffective Executive Compensation Management
We are sometimes critical of CEO compensation packages, yet we are first to admit that CEOs have an outsized influence on the future prospects of companies large and small. This is particularly true of fast-moving industries such as technology where having the correct CEO in place may mean catching the latest technology wave - cloud, … Continue reading CEOs – The Most Undervalued Investment Variable
Tesla CEO Elon Musk's $2.3 Billion compensation package is an example of poor corporate governance and a self-serving Board (ACCESS Our Commentary HERE). For examples of how to run a business well and fairly compensate CEOs for performance - look no further than CoStar (tkr: CSGP) and SS&C (tkr: SSNC). Our CSGP and SSNC data … Continue reading Tesla’s $2.3 Billion CEO Compensation Package
We have updated our CEO Compensation & Pay Disclosure data to reflect Friday's 14A filings. Further, we have segmented our data (ACCESS CEORater's Segmented Data Tables HERE). Page ONE is a summary page, followed by FINTECH companies, LARGE CAP, MID CAP and SMALL CAP companies. Last, we include the Full Universe.
Some CEOs help generate significant returns, while others are content to watch the world burn... Lyft is off 22% from its $72 IPO price, but we will save the glorified taxi discussion for another day. We calculated CEO Pay Ratios for a number of CEOs and Board chairs (ACCESS OUR DATA HERE). Should you wish … Continue reading CEO Pay Ratios